Acta Neurologica Scandinavica

Cover image for Acta Neurologica Scandinavica

November 1989

Volume 80, Issue Supplement s126

Pages 5–219

    1. List of contributors (page 5)

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01775.x

    2. Preface (page 9)

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01776.x

    3. Epidemiological approaches to the etiology of Parkinson's disease (pages 13–18)

      R. J. Marttila and U. K. Rinne

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01777.x

    4. Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease (pages 19–22)

      E. C. Hirsch, A. M. Graybiel and Y. Agid

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01778.x

    5. MPTP-induced parkinsonism as a model for Parkinson's disease (pages 35–40)

      J. W. Tetrud and J. W. Langston

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01780.x

    6. Neurochemical perspectives to the function of monoamine oxidase (pages 41–45)

      P. Riederer, C. Konradi, G. Hebenstreit and M.B.H. Youdim

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01781.x

    7. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? (pages 47–54)

      M.B.H. Youdim, D. Ben-Shachar and P. Riederer

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01782.x

    8. Brain dopaminergic mechanisms in Parkinson's disease evaluated by positron emission tomography (pages 55–59)

      S.-M. Aquilonius, B. Långström and J. Tedroff

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01783.x

    9. Strategy and tactic of modern Parkinson therapy (pages 63–66)

      W. Birkmayer and G.J.D. Birkmayer

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01784.x

    10. Objective measurement of motor disability in Parkinson's disease (pages 67–75)

      G. Steg, P. E. Ingvarsson, B. Johnels, M. Valls and M. Thorselius

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01785.x

    11. The pharmacology of selegiline ((−)deprenyl). New aspects (pages 83–91)

      J. Knoll

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01787.x

    12. Pharmacokinetics and metabolism of selegiline (pages 93–99)

      Heinonen E H, Myllylä V, Sotaniemi K, Lammintausta R, Salonen J S, Anttila M, Savijärvi M, Kotila M and Rinne U K

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01788.x

    13. Selegiline in the treatment of Parkinson's disease (pages 103–111)

      Heinonen E H and Rinne U K

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01789.x

    14. Combination of selegiline and controlled release levodopa in the treatment of fluctuations of clinical disability in parkinsonian patients (pages 127–137)

      C. Chouza, R. Aljanati, A. Scaramelli, O. De Medina, J.L. Caamaño, R. Buzo, A. Fernandez and S. Romero

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01792.x

    15. New approaches in the use of selegiline for the treatment of Parkinson's disease (pages 139–145)

      A. J. Lees, J. Frankel, V. Eatough and G. M. Stern

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01793.x

    16. Selegiline and levodopa in early or moderately advanced Parkinson's disease: a double-blind controlled short- and long-term study (pages 147–152)

      B. Sivertsen, E. Dupont, B. Mikkelsen, P. Mogensen, C. Rasmussen, F. Boesen and E. Heinonen

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01794.x

    17. Selegiline in the treatment of Parkinson's disease — long term experience (pages 157–161)

      M. D. Yahr, T. S. Elizan and D. Moros

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01796.x

    18. Deprenyl and tocopherol antioxidative therapy of parkinsonism (DATATOP) (pages 171–175)

      I. Shoulson

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01798.x

    19. Selegiline as primary treatment in early phase Parkinson's disease — an interim report (pages 177–182)

      V. V. Myllylä, K. A. Sotaniemi, J. Tuominen and E. H. Heinonen

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01799.x

    20. Adrenal medullary transplants as a treatment for advanced Parkinson's disease (pages 189–196)

      A. Lieberman, J. Ransohoff, P. Berczeller, P. Brous, K. Eng, M. Goldstein, B. Kaufman, M. Koslow and L. Chin

      Article first published online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1989.tb01801.x

SEARCH

SEARCH BY CITATION